- Home
- KOSS vs CMRX Comparison
KOSS vs CMRX Comparison
Compare KOSS & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- CMRX
- Stock Information
- Founded
- KOSS 1953
- CMRX 2000
- Country
- KOSS United States
- CMRX United States
- Employees
- KOSS N/A
- CMRX N/A
- Industry
- KOSS Consumer Electronics/Appliances
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- CMRX Health Care
- Exchange
- KOSS Nasdaq
- CMRX Nasdaq
- Market Cap
- KOSS 63.0M
- CMRX 77.0M
- IPO Year
- KOSS N/A
- CMRX 2013
- Fundamental
- Price
- KOSS $7.34
- CMRX $0.93
- Analyst Decision
- KOSS
- CMRX Strong Buy
- Analyst Count
- KOSS 0
- CMRX 1
- Target Price
- KOSS N/A
- CMRX $11.00
- AVG Volume (30 Days)
- KOSS 183.8K
- CMRX 119.4K
- Earning Date
- KOSS 11-08-2024
- CMRX 11-08-2024
- Dividend Yield
- KOSS N/A
- CMRX N/A
- EPS Growth
- KOSS N/A
- CMRX N/A
- EPS
- KOSS N/A
- CMRX N/A
- Revenue
- KOSS $12,265,069.00
- CMRX $144,000.00
- Revenue This Year
- KOSS N/A
- CMRX $3,040.12
- Revenue Next Year
- KOSS N/A
- CMRX N/A
- P/E Ratio
- KOSS N/A
- CMRX N/A
- Revenue Growth
- KOSS N/A
- CMRX N/A
- 52 Week Low
- KOSS $2.27
- CMRX $0.75
- 52 Week High
- KOSS $18.73
- CMRX $1.30
- Technical
- Relative Strength Index (RSI)
- KOSS 50.17
- CMRX 60.78
- Support Level
- KOSS $7.00
- CMRX $0.80
- Resistance Level
- KOSS $7.83
- CMRX $0.98
- Average True Range (ATR)
- KOSS 0.44
- CMRX 0.05
- MACD
- KOSS -0.01
- CMRX 0.01
- Stochastic Oscillator
- KOSS 32.26
- CMRX 83.33
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.